In
Gregory Ford
Profile
Greg Ford always thought he wanted a career that involved business. It was a presentation on Industrial Engineering that helped him decide on his college major. “IE was the only engineering major that talked about how you could use your degree in the business world. That’s what convinced me,” Greg remembers.
His first two years of college were a struggle. He met his future wife when he was a sophomore. He struggled with maintaining focus. When he moved into his junior year and started taking his IE courses, he became more focused. Project groups really helped him stay on track. He also got a lot of help from his advisor.
After graduation, he had a chance to interview with Mylan. His advisor helped him with the confidence he needed to do well in the interview. He got the job and stayed at Mylan for 13 years. When Greg finished his career at Mylan, his office was just down the hall from Mike Puskar, the founder of Mylan. “Mike was a wonderful leader and mentor,” Greg says.
Greg was being recruited to join other pharmaceutical companies. The next phase of Greg’s career involved a series of senior leadership positions of pharmaceutical companies. A lot of his work at this time was new business development.
Currently Greg is involved in buying pharmaceutical assets and then repositioning them for sale. These transactions have had valuations worth close to $1 billion dollars. These are very complex transactions and Greg is often across the table from Ivy League MBA’s. “I’m proud to say that my WVU IE and MBA degrees have given me the training I needed to successfully compete against graduates from what many individuals perceive as more prestigious institutions,” Greg says.
Two things that Greg is still proud of are finding a mistake in the Finance book used in his MBA course. He reported the error to the author and received a cash award in recognition. He also got a personal letter from his Economics teacher in his MBA program commending him for getting a 100% on the final and being the top student tin the class.
“I could have given up in my first two years,” Greg recalls, “but my advisor gave me the confidence that I could succeed. I am very proud to have graduated from WVU and appreciative with the learnings I received in my IE and MBA courses.
Bio
Greg Ford is a proven leader with expertise in commercialization of products and technologies. He is skilled in recognizing and implementing value creating opportunities and collaborations. Competencies include all aspects of operational management, strategic planning, and corporate/business development. Track record of turning good ideas into profitable businesses and intellectual properties. A self-motivated professional with a strong desire to succeed and provide others with guidance and methods for success.
PROFESSIONAL EXPERIENCE
KFE, LLC
CEO – 2016 – current
- Sold two assets for cash consideration of $500 million.
MATAWAN PHARMACEUTICALS, LLC
President – 2014 – current
CRANFORD PHARMACEUTICALS, LLC
President – 2014 – current
AKRIMAX PHARMACEUTICALS, LLC
VP, Corporate Development, 2011 – current
- Closed 3 business transactions with valuation of over $500 million in NPV.
- Responsible for all corporate and business development for Krivulka/Mazur family of companies including: Akrimax Pharmaceuticals, LLC (cardiovascular, endocrinology, metabolic, and birth control products); Triax Pharmaceuticals, LLC (dermatology and hospital products); Rouses Point Generics (generic products); and DCR Acquisition, LLC.
- Successfully identified products for companies above and heavily involved in financing same by working with outside investors. Currently working on closing an undisclosed multimillion dollar financing.
FORDPHARMA CONSULTING
President, 2010 – current
- Consulting services for small to mid-sized biopharma companies.
- Services provided include: business plans/strategic plans, market assessments, forecasting/financial modeling, product & technology assessments, due diligence, business development/corporate development assistance, alternative partnering assessments.
POLYMEDIX, INC.
Vice President, Business Development, Company Officer, 2008 – 2009
COLLAGENEX PHARMACEUTICALS INC. (ACQUIRED BY GALDERMA LABORATORIES)
Vice President, Business Development and Strategic Planning, Company Officer, 2004 – 2008
SKYEPHARMA/RTP PHARMA , 1999 – 2004
SKYEPHARMA US INC.
Vice President, Global Business Development, 2003 –2004
SKYEPHARMA CANADA, INC (RTP PHARMA INC.)
President, Officer and Board Member, 2002 – 2003
RTP PHARMA INC.
President and Chief Operating Officer, Board Member, 2001 – 2002
RTP PHARMA INC.
Vice President, Business Development, 1999 – 2001
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Associate Director, Business Development, 1997 – 1999
MYLAN LABORATORIES/MYLAN PHARMACEUTICALS, 1985 – 1997
MYLAN LABORATORIES, INC.
Associate Director, Corporate Business Development, 1996 – 1997
MYLAN LABORATORIES, INC.
Manager, Corporate Business Development, 1992 – 1996
MYLAN PHARMACEUTICALS, INC.
Quality Assurance Manager – Main Plant, 1990 – 1992
MYLAN PHARMACEUTICALS, INC.
Production Supervisor, Compressing – Main Plant, 1988 – 1990
MYLAN PHARMACEUTICALS, INC.
Production Supervisor – Penicillin Plant, August 1985 – 1988
EDUCATION
WEST VIRGINIA UNIVERSITY
Masters of Business Administration, 1990
WEST VIRGINIA UNIVERSITY
Bachelors of Science, Industrial Engineering, 1985
